Arcturus Therapeutics Holdings (ARCT) Other Non-Current Liabilities (2021 - 2023)

Arcturus Therapeutics Holdings has reported Other Non-Current Liabilities for 3 years, with the latest figure at $497000.0 in Q4 2023.

• For the quarter ending Q4 2023, Other Non-Current Liabilities fell 82.28% year-over-year to $497000.0; the trailing twelve-month figure through Dec 2023 stood at $497000.0 (down 82.28% YoY), and the FY2023 full-year result was $497000.0, down 82.28% from the prior year.
• Other Non-Current Liabilities for Q4 2023 stood at $497000.0, down from $976000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $3.7 million in Q3 2022, with the low at $358000.0 in Q1 2021.
• Historically, Other Non-Current Liabilities has averaged $1.5 million across 3 years, with a median of $1.3 million in 2023.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 163.7% — and 2023, when it sank 82.28%.
• Arcturus Therapeutics Holdings' Other Non-Current Liabilities stood at $1.4 million in 2021, then surged by 101.15% to $2.8 million in 2022, then slumped by 82.28% to $497000.0 in 2023.
• The last three Other Non-Current Liabilities figures came in at $497000.0 (Q4 2023), $976000.0 (Q3 2023), and $1.3 million (Q2 2023), per Business Quant data.